• Lilly’s CEO Lechleiter Plans Surgery for Dilated Artery
  • Oxford Works With Drugmakers to Reverse 90% Trial Failure Rate
  • Merck Cuts Profit Forecast as Buyback Boosted $15 Billion
  • Eli Lilly Sues J&J for Patents Rights in Alzheimer Drug Race
  • Eli Lilly Profit Beats Estimates on Lower Costs
  • Lilly’s Lechleiter Says R&D Is Company's `Lifeblood’ (Audio)
  • Lilly Looking for Areas to Cut Costs, CEO Says
« Previous 1 2 Next »